Utilizing the data of the CheckMate 9ER trial, researchers believe that combination therapies in the treatment of patients with renal cell carcinoma are the future of the landscape.
Bradley McGregor, M.D.
Advertisement
Articles by Bradley McGregor, M.D.
Advertisement
Latest Updated Articles
Combination Therapies Open New Doors in Renal Cell Carcinoma StudiesFebruary 25th 2020
Advertisement
Advertisement
Trending on CURE
1
Nurse's Insight Sparks Breakthrough Research in Pregnancy and MPN Care
2
FDA Approves Trodelvy Alone or With Keytruda for First-Line Triple-Negative Breast Cancer
3
FDA Approves Ibrance Combo for Maintenance Treatment of HR-Positive, HER2-Positive Metastatic Breast Cancer
4
Oncologist Answers Most Common Questions About Cell Therapy
5